MIAN
IHE icon

Mariner Independent Advisor Network’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mariner Independent Advisor Network’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-109,218
Closed -$5.5M – 248
2017
Q1 		$5.5M Buy
+109,218
New +$5.41M 0.67% 33

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mariner Independent Advisor Network's IHE Position: Q2 2017 in Review

Mariner Independent Advisor Network sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2017, closing a stake of 109,218 shares — an estimated $5.5M sold.

Mariner Independent Advisor Network first reported a position in IHE in Q1 2017 and held it in 1 quarter. The position peaked at $5.5M in Q1 2017. 95 funds tracked by Wall St. Rank hold IHE as of Q2 2017.

  • Mariner Independent Advisor Network reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 109,218 iShares US Pharmaceuticals ETF shares in Q2 2017, an estimated $5.5M.
  • Mariner Independent Advisor Network first reported a position in iShares US Pharmaceuticals ETF in Q1 2017 and held it in 1 quarter.
  • Mariner Independent Advisor Network's iShares US Pharmaceuticals ETF position peaked at $5.5M in Q1 2017.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2017.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2017, filed 16 Aug 2017.